Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 185 clinical trials
Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus

Aim To investigate the effect of sentinel lymph node (SLN) sampling on the prognosis of patients with middle-high risk endometrial cancer obviously confined to the uterus before surgery.

  • 0 views
  • 08 Apr, 2023
  • 1 location
Urinary Human Papilloma Virus Test in the General Population in Brittany (PapU-Access)

cervical cancer screening of the uterus, in the 4 Breton departments, will be proposed after stratification by age and socio-economic level at the revival of the cervical cancer of the uterus screening by

KIT
  • 0 views
  • 04 Oct, 2022
  • 1 location
HPV Self-Sampling in Somali Women (Isbaar)

This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.

  • 0 views
  • 04 Apr, 2023
  • 1 location
SMS-based Summons in Cervical Screening

Prevention of cervical cancer with cervical screening (gynecological cell test) is one of the most successful screening activities in medicine. In Sweden screening has taken place since the 1960s and prevented tens of thousands of women from having cervical cancer. There are strong reasons why it is especially important to …

hpv test
cancer
prevention of cervical cancer
primary cancer
  • 0 views
  • 29 Apr, 2022
  • 6 locations
A Proximity-incentive Strategy for Cervical Cancer Screening (RIDECA)

In France, cervical cancer screening is based on a cervical smear for women aged 25 to 30 years and on High Risk- HPV (HR-HPV) testing for women aged 30 to 65 years. One of the main concerns in France is poor attendance to this screening program, up to 40% of …

hpv test
human papillomavirus dna
cervical cancer screening
smear
breast cancer
  • 0 views
  • 25 Mar, 2022
A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations

This trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this trial have either spread to other parts of the body (metastatic) or cannot be removed completely with surgery (unresectable). …

cancer chemotherapy
mammogram
HER2
fulvestrant
metastatic cervical cancer
  • 27 views
  • 27 Oct, 2022
  • 61 locations
Letrozole in Stimulated IVF Cycles

. One of the reasons is an adverse effect of high serum estradiol levels following FSH stimulation on the lining of the uterus. Letrozole is a drug used in the prevention of recurrence of breast

estrogen
follicle stimulating hormone
cetrotide
clomiphene
antral follicle count
  • 395 views
  • 19 Apr, 2022
  • 2 locations
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relationships, sexuality and sexual activity, and

endometriosis
elagolix
combined oral contraceptives
dysmenorrhea
  • 1459 views
  • 20 Sep, 2023
  • 108 locations
Sentinel Node Biopsy in Endometrial Cancer (ENDO-3)

Endometrial cancer (EC) is the most common gynaecological cancer. Current treatment of EC typically includes removal of the uterus and to determine the extent of the disease (removal of

  • 0 views
  • 07 Oct, 2022
  • 5 locations
GEN1047 for Solid Tumors - First in Human (FIH) Trial

The drug investigated in the study is an antibody, GEN1047. Since this is the first study of GEN1047 in humans, the main purpose is to evaluate safety. Besides safety, the study will determine the recommended GEN1047 dose to be tested in a larger group of participants and assess preliminary clinical …

ovarian cancer
cancer antigen 125
measurable disease
cancer
breast cancer
  • 4 views
  • 11 Aug, 2023
  • 8 locations